At approximately what gestational age does surfactant production begin in the foetal alveolar type II cells?

BTSC Staff Nurse 31 July-2025

Obstetrics & Gynaecology

Easy

Appeared in: BTSC Staff Nurse 31 July-2025

Explanation

Surfactant production is initiated by secretory type II pneumocytes at approximately 24 weeks of gestation.
Surfactant is a lipoprotein that lowers the surface tension in the alveoli, preventing them from collapsing during expiration and thus reducing the work of breathing.
While production begins at 24 weeks, sufficient quantities for stable lung function are typically not available until later in gestation, around 34-36 weeks.
The period from 24 weeks marks a critical point in fetal viability, as the potential for gas exchange begins, although it is still highly inefficient.

Option A: At 18 weeks, the fetal lungs are in the late pseudoglandular or early canalicular stage. The specialized type II pneumocytes that produce surfactant have not yet fully differentiated or begun secretion.
Option C: At 16 weeks, the lungs are transitioning from the pseudoglandular to the canalicular stage. The cellular machinery for surfactant synthesis is not yet in place.
Option D: At 12 weeks, the fetal lungs are in the pseudoglandular stage, appearing more like a gland than a respiratory organ. There are no developed alveoli or type II pneumocytes.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Fetal lung development and surfactant production timeline as background academic context rather than a clinical decision trigger.
Understanding the timeline of surfactant production is crucial for assessing the viability and potential complications of a preterm neonate. Infants born before 24 weeks have extremely low survival rates largely due to respiratory failure.
This knowledge underpins the practice of administering antenatal corticosteroids to mothers at risk of preterm delivery between 24 and 34 weeks. These steroids accelerate the maturation of fetal lungs and stimulate surfactant production, reducing the severity of Respiratory Distress Syndrome (RDS).
Nurses in the NICU must be prepared to manage infants with RDS, which includes administering exogenous surfactant therapy and providing respiratory support.

How to Approach the Question

First, identify the core of the question, which is asking for a specific timeline in fetal development: the start of surfactant production.
This is a factual recall question. Access your knowledge of fetal physiology and key developmental milestones.
Recall the stages of fetal lung development: pseudoglandular, canalicular, terminal sac, and alveolar.
Associate the start of surfactant production with the correct stage. Surfactant-producing cells (type II pneumocytes) appear and begin functioning during the canalicular stage.
Match the gestational age to the stage. The canalicular stage occurs from approximately 16 to 25 weeks, with surfactant secretion beginning around 24 weeks.
Evaluate the given options. 12, 16, and 18 weeks are too early. 24 weeks aligns with the known timeline for the initiation of surfactant secretion.

Concept Tested & Keywords

Concept Tested: Fetal lung development and surfactant production timeline.
Stem keywords: surfactant production, gestational age, foetal alveolar type II cells
Lead-in keywords: approximately what

Q-hS8eod06CNZrTsxNrnir

E6 Obstetrics Williams pp. 20-36, 25-43